Fundraising Fox

Iambic Therapeutics, Inc.

San Diego, US · Founded 2019 · Delaware corporation · 4 known investors

Biotech

Founders & leadership

JB
Jishnu BhattacharjeeDirector
WR
William RastetterDirector
FM
Fred ManbyExecutive Officer, Director
SS
Shalini SharpDirector
NJ
Neil JosephsonExecutive Officer
MS
Michael SecoraExecutive Officer
RJ
R. Jacob VogelsteinDirector
MT
Mary TagliaferriDirector
ER
Evan RachlinDirector
TM
Thomas MillerExecutive Officer, Director
PO
Pete OlsonExecutive Officer
KV
Kurt von EmsterDirector

Investors · 4

AbingworthreportedLondon · $15M – $30Mvia Kurt von Emster · board
Abingworth BioventuresreportedLondon
Nexus Venture PartnersreportedPort Louis, Port Louis · $500K – $10Mvia Jishnu Bhattacharjee · board
Nexus VenturesreportedMenlo Park

Reported raises · per SEC filings

Form D private placements
▶$27.8MraisedApr 2026 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shalini SharpDirector
  • R. Jacob VogelsteinDirector
  • Thomas MillerExecutive Officer, Director
  • Fred ManbyExecutive Officer, Director
  • Michael SecoraExecutive Officer
  • Neil JosephsonExecutive Officer
  • Mary TagliaferriDirector
  • Kurt von EmsterDirector
  • William RastetterDirector
  • Jishnu BhattacharjeeDirector
  • Evan RachlinDirector
  • Pete OlsonExecutive Officer
Offering amount
$50M
Amount sold
$27.8M
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$99.3MraisedNov 2025 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jishnu BhattacharjeeDirector
  • William RastetterDirector
  • Fred ManbyExecutive Officer, Director
  • Shalini SharpDirector
  • Neil JosephsonExecutive Officer
  • Michael SecoraExecutive Officer
  • R. Jacob VogelsteinDirector
  • Mary TagliaferriDirector
  • Evan RachlinDirector
  • Thomas MillerExecutive Officer, Director
  • Pete OlsonExecutive Officer
  • Kurt von EmsterDirector
Offering amount
$125M
Amount sold
$99.3M
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38.4MraisedJun 2024 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas MillerExecutive Officer, Director
  • Tabbert TengExecutive Officer
  • William RastetterDirector
  • Evan RachlinDirector
  • Fred ManbyExecutive Officer, Director
  • R. Jacob VogelsteinDirector
  • Kurt von EmsterDirector
  • Jishnu BhattacharjeeDirector
  • Neil JosephsonExecutive Officer
Offering amount
$50M
Amount sold
$38.4M
First sale
Apr 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$103.2MraisedOct 2023 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Fred ManbyExecutive Officer, Director
  • R. Jacob VogelsteinDirector
  • Chao ZhangExecutive Officer
  • Evan RachlinDirector
  • Tabbert TengExecutive Officer
  • Thomas MillerExecutive Officer, Director
  • William RastetterDirector
  • Kurt von EmsterDirector
  • Jishnu BhattacharjeeDirector
Offering amount
$110M
Amount sold
$103.2M
First sale
Sep 2023
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.